504 related articles for article (PubMed ID: 19376416)
1. Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin with rapamycin plus tacrolimus in liver transplant patient.
Dopazo C; Bilbao I; Lázaro JL; Sapisochin G; Caralt M; Blanco L; Castells L; Charco R
Transplant Proc; 2009 Apr; 41(3):1021-4. PubMed ID: 19376416
[TBL] [Abstract][Full Text] [Related]
2. Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin, amiodarone, and atazanavir.
Schmidt GA; Hoehns JD; Purcell JL; Friedman RL; Elhawi Y
J Am Board Fam Med; 2007; 20(4):411-6. PubMed ID: 17615423
[TBL] [Abstract][Full Text] [Related]
3. Rhabdomyolysis and acute renal failure in a cardiac transplant recipient due to multiple drug interactions.
Kusus M; Stapleton DD; Lertora JJ; Simon EE; Dreisbach AW
Am J Med Sci; 2000 Dec; 320(6):394-7. PubMed ID: 11149552
[TBL] [Abstract][Full Text] [Related]
4. Rhabdomyolysis in a Prostate Cancer Patient Taking Ketoconazole and Simvastatin: Case Report and Review of the Literature.
Watkins JL; Atkinson BJ; Pagliaro LC
Ann Pharmacother; 2011 Feb; 45(2):e9. PubMed ID: 21304039
[TBL] [Abstract][Full Text] [Related]
5. Severe rhabdomyolysis associated with concurrent use of simvastatin and sirolimus after cisplatin-based chemotherapy in a kidney transplant recipient.
Hong YA; Kim HD; Jo K; Park YK; Lee J; Sun IO; Chung BH; Park CW; Yang CW; Choi BS
Exp Clin Transplant; 2014 Apr; 12(2):152-5. PubMed ID: 23734754
[TBL] [Abstract][Full Text] [Related]
6. Rhabdomyolysis in association with simvastatin and amiodarone.
Roten L; Schoenenberger RA; Krähenbühl S; Schlienger RG
Ann Pharmacother; 2004 Jun; 38(6):978-81. PubMed ID: 15069169
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin-induced rhabdomyolysis in a CsA-treated renal transplant recipient.
Gumprecht J; Zychma M; Grzeszczak W; Kuźniewicz R; Burak W; Zywiec J; Karasek D; Otulski I; Mosur M
Med Sci Monit; 2003 Sep; 9(9):CS89-91. PubMed ID: 12960932
[TBL] [Abstract][Full Text] [Related]
8. Improvement of renal function after conversion to mycophenolate mofetil combined with low-level calcineurin inhibitor in liver transplant recipients with chronic renal dysfunction.
Ponton C; Vizcaíno L; Tomé S; Otero E; Molina E; Castroagudín JF; López-Lago A; Varo Pérez E
Transplant Proc; 2010 Mar; 42(2):656-9. PubMed ID: 20304216
[TBL] [Abstract][Full Text] [Related]
9. Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin.
Lee AJ; Maddix DS
Ann Pharmacother; 2001 Jan; 35(1):26-31. PubMed ID: 11197581
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil monotherapy in patients who underwent liver transplantation for hepatitis C cirrhosis.
Manrique A; Jiménez C; Ortega P; Abradelo M; Gimeno A; Calvo J; Cambra F; -Sterup RL; Morales JM; Moreno E
Transplant Proc; 2008 Nov; 40(9):2962-4. PubMed ID: 19010160
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin-induced rhabdomyolysis in a patient with chronic renal failure.
Al Shohaib S
Am J Nephrol; 2000; 20(3):212-3. PubMed ID: 10878403
[TBL] [Abstract][Full Text] [Related]
12. Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY study.
Karie-Guigues S; Janus N; Saliba F; Dumortier J; Duvoux C; Calmus Y; Lorho R; Deray G; Launay-Vacher V; Pageaux GP
Liver Transpl; 2009 Sep; 15(9):1083-91. PubMed ID: 19718632
[TBL] [Abstract][Full Text] [Related]
13. Four-year follow-up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantation.
Fisher RA; Stone JJ; Wolfe LG; Rodgers CM; Anderson ML; Sterling RK; Shiffman ML; Luketic VA; Contos MJ; Mills AS; Ferreira-Gonzalez A; Posner MP
Clin Transplant; 2004 Aug; 18(4):463-72. PubMed ID: 15233827
[TBL] [Abstract][Full Text] [Related]
14. [Case report of introducing MMF and steroids as an immunosuppressive therapy after living-donor liver transplantation for a patient with the diabetic nephropathy].
Kuramitsu S; Iguchi T; Ninomiya M; Yamashita Y; Harimoto N; Ikegami T; Uchiyama H; Yoshizumi T; Soejima Y; Shirabe K; Kawanaka H; Ikeda T; Furuta T; Tamada R; Maehara Y
Fukuoka Igaku Zasshi; 2014 Mar; 105(3):79-83. PubMed ID: 25000660
[TBL] [Abstract][Full Text] [Related]
15. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
Tönshoff B; Höcker B
Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
[TBL] [Abstract][Full Text] [Related]
16. Atypical calcineurin inhibitor-induced haemolytic uremic syndrome after liver transplantation.
Furmańczyk A; Komuda-Leszek E; Durlik M
Ann Transplant; 2009; 14(4):47-51. PubMed ID: 20009155
[TBL] [Abstract][Full Text] [Related]
17. Hyperkalemic distal renal tubular acidosis caused by immunosuppressant treatment with tacrolimus in a liver transplant patient: case report.
Riveiro-Barciela M; Campos-Varela I; Tovar JL; Vargas V; Simón-Talero M; Ventura-Cots M; Crespo M; Bilbao I; Castells L
Transplant Proc; 2011 Dec; 43(10):4016-8. PubMed ID: 22172892
[TBL] [Abstract][Full Text] [Related]
18. [Maximal initial dose of simvastatin causing acute renal failure through rhabdomyolysis: risk factors, pathomechanism and therapy related to a case].
Deme D; Al-Hadad A; Varga T; Szántó E; Sándor K; Rakonczai E
Orv Hetil; 2009 Feb; 150(6):265-9. PubMed ID: 19179259
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppression based on mycophenolate mofetil in stable liver transplanted patients.
Bilbao I; Castells L; Rojas L; Cancino J; Dopazo C; Castro E; Pou L; Andino R; Margarit C
Int Immunopharmacol; 2006 Dec; 6(13-14):1977-83. PubMed ID: 17161351
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.
Gonwa T; Mendez R; Yang HC; Weinstein S; Jensik S; Steinberg S;
Transplantation; 2003 Apr; 75(8):1213-20. PubMed ID: 12717205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
